Abstract
Antimyosin (Myoscint ™ Centocor Inc. Malvern PA) is a Fab fragment of a specific antibody to myosin heavy chains that binds to necrotic cardiac myocytes. Planar or single photon emission computed tomography (SPECT) techniques using Indium- 111 labelled antibody have been used for the clinical detection of myocardial necrosis, both in acute myocardial infarction, and in myocarditis. This article reviews the role of antimyosin (AM) imaging in myocardial infarction diagnosis and risk stratification.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Khaw B.Aet al(1979) Specificity of localisation of myosin-specific antibody fragments in experimental myocardial infarction: histologie, histochemical, autoradiographic and scintigraphic studies. Circulation 60, 1527–1531
Frame L.H et al (1983) Early membrane damage during coronary reperfusion in dogs: detection by radiolabelled anticardiac myosin (Fab’)2 J. Clin. Invest/ 72, 535–544
khaw B.A. et al (1980) Myocardial infarct imaging of antibodies to canine myosin with Indium-111-diethylene-triaminepentaaceticacid, Science 209, 295–297
Khaw B.A et al (1984) Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction, Hybridoma 3, 11–23
Khaw B.A et al (1982) Myocardial injury: quantification by cell sorting initiated with antimyosin fluorescent spheres, Science 217: 1050–1053
Khaw B.A et al (1987) Myocardial damage delineated by indium-111 antimyosin Fab and technetium-99m pyrophosphate. J. Nucl. Med. 28: 76–82
Johnson L.L. et al (1987) Measurementof infarct size and percentagemyocardiuminfarcted in a dog preparation with single photon-emission computed tomography, thallium-201 and indium 111-monoclonal antimyosin Fab. Circulation 76: 181–190
Narula J et al (1990) Documentation of re perfusion myocardial injury by dual radiolabelled anti-myosin imaging: reversibility by membrane stabilising agent. J. Nucl. Med. 31: 805 (Abstract)
Nedelman MA et al (1990) Evaluation of antimyosin uptake in reversiblyinjured (’stunned) myocardium J. Nucl. Med. 31: 783 (Abstract)
Jain D. et al (1988) Postmortem correlation between histopathologic and autoradiographic extent of myocardial necrosis detected by 111-In-antimyosinimagingin a patientswith acute myocardial infarction. Am. J. CardiacImaging 2: 158–161
Jain D et al (1990) Indium-111 antimyosin images compared with triphenyl tetrazolium chloride staining in a patient six days after myocardial infarction. J. Nucl. Med. 31: 231–233
Tamaki N et al (1989) (Clinicaltrial of 111-In-antimyosinantibody imaging (3) Comparison with 99mTc-pyrophosphateimaging) Kaku Igaku 26: 1199–1205
Jain D et al (1989) Late imaging of myocardial infarction with In-111 antimyosin antibodies. Eur.J. Nucl. Med. 15: 474 (Abstract)
Liu XJ et al (1990) A quantitative method for assessing age of myocardial infarction from antimyosin images. J. Nucl. Med. 31: 782 (Abstract)
Jain D et al (1990) Immunoscintigraphyfor the detection of acute myocardial infarction in the absence of electrocardiographicchanges. Br. Med. J. 300: 151–153
Morguet A et al (1989) Tc-99m methoxy-isobutyl-isonitrile (MIBI) for anatomical landmarking in imaging acute myocardial infarction (AMI) with antimyosin Fab (AM Fab) J. Nucl. Med. 30: 800 (Abstract)
Knapp W.H. et al (1989) In-111 antimyosin antibodies and Tc-99m-MIBIfor assessment of post-infarction myocardial viability. J. Nucl. Med. 30: 800 (Abstract)
Johnson L.L. and Seldin D.W. (1989) The role of antimyosin antibodies in acute myocardial infarction. Semin. Nucl. Med. 19: 238–246
Jain D et al (1988) Discordance between In-111 antimyosin uptake, regional perfusion and wall motion abnormalities in acute Q-wave myocardial infarction. Circulation 78: Supply. 11 431 (Abstract)
Khaw B.A. et al (1989) Scintigraphicquantificationof myocardial necrosis in patients after intravenous injection of myosin-specific antibody. Circulation 74: 501–508
Antunes M.L. et al (1989) Measurement of acute Q-wave myocardial infarct size with single photon emission computed tomography imaging of indium-111 antimyosin. Am. J.Cardiol. 63: 777–783
Volpini M. et al (1989) Diagnosis of acute myocardial infarction by indium-111 antimyosin antibodies and correlation with the traditional techniques for the evaluation of extent and localisation. Am J. Cardiol. 63: 7–13
Berger H. et al (1988) Antimyosin imaging in patients with ischemic chest pain: initial results of phase 111 multicentre trial. J. Nucl. Med. 29 805 (Abstract)
Lahiri A. et al (1990) Combined assessment of myocardial necrosis and left ventricular function with a single dose of In-111 antimyosin J. Nucl. Med. 31: 841 (Abstract)
Khaw B.A. et al (1989) Modification of monoclonal antimyosin antibody: enhanced specificity of localisation and scintigraphic visualisation in acute experimental myocardial infarction. J. Mol. Cell Cardiol. 21:Supply 1. 31–35
Kader K.L. et al (1990) Rapid localisation of In-111 labelled recombinant tissue plasminogen activator in a rabbit thrombosis model J. Nucl. Med. 31: 805 (Abstract)
Chouraqui P. et al (1990) Successful in vivo visualisation of occlusive arterial thrombi by Tc-99m labelled monoclonal antibody against activated platelets. J. Nucl. Med. 30: 713 (Abstract)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Bhattacharya, S., Lahiri, A. (1991). Antimyosin Antibody Imaging in Myocardial Infarction. In: Baum, R.P., Cox, P.H., Hör, G., Buraggi, G.L. (eds) Clinical Use of Antibodies. Developments in Nuclear Medicine, vol 19. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3516-0_7
Download citation
DOI: https://doi.org/10.1007/978-94-011-3516-0_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5555-0
Online ISBN: 978-94-011-3516-0
eBook Packages: Springer Book Archive